Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → HCID 25253839, Verbindung
Reaktionsgleichung
[CH:1]1([N:7]2[CH2:13][C:12]([F:15])([F:14])[C:11](=[O:16])[N:10]([CH3:17])[C:9]3[CH:18]=[N:19][C:20]([NH:22][C:23]4[CH:31]=[CH:30][C:26]([C:27]([OH:29])=O)=[CH:25][C:24]=4[O:32][CH3:33])=[N:21][C:8]2=3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.CN(C(ON1N=[N:49][C:44]2[CH:45]=C[CH:47]=[N:48][C:43]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.Cl.CN1CC(N)C1>>[CH:1]1([N:7]2[CH2:13][C:12]([F:15])([F:14])[C:11](=[O:16])[N:10]([CH3:17])[C:9]3[CH:18]=[N:19][C:20]([NH:22][C:23]4[CH:31]=[CH:30][C:26]([C:27]([NH:49][CH:44]5[CH2:43][N:48]([CH3:47])[CH2:45]5)=[O:29])=[CH:25][C:24]=4[O:32][CH3:33])=[N:21][C:8]2=3)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1Komponenten
4
Edukt 3
Produkt 1
Versuchsvorschrift
The title compound was synthesized from 4-(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[5,4-b][1,4]diazepin-2-ylamino)-3-methoxybenzoic acid as described in the General procedure for amide bond synthesis using HATU and 1-methylazetidin-3-amine hydrochloride. The final compound was purified by reverse phase HPLC and basified to give the free base. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.18-1.82 (m, 12H) 2.32 (s, 3H) 3.10 (s, 3H) 3.62 (s, 2H) 3.95 (s, 3H) 4.06 (t, J=13.4 Hz, 2H) 4.47 (m, 1H) 4.45 (d, J=6.8 Hz, 1H) 7.49 (d, J=8.1 Hz, 1H) 7.53 (s, 1H) 7.90 (s., 1H) 8.21 (s, 1H) 8.28 (d, J=8.1 Hz, 1H) 8.65 (d, J=5.8 Hz, 1H). [M+H] calc'd for C26H33F2N7O3, 530. found 530.
Aufarbeitung
- customas described in the General procedure for amide bond synthesis
- customThe final compound was purified by reverse phase HPLC
- customto give the free base
Quellen und Nachweise
- ORD-Eintrag
- ord-a2f2a64b988c4798a9fa4a61678fd08b
- Quelldatensatz
- uspto-grants-2011_09
- Patentnummer
- US08026234B2
Notizen zur Reaktion
Wird geladen…